Vertex Pharma (VRTX) call put ratio 2.8 calls to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mail
Get Alerts VRTX Hot Sheet
Join SI Premium – FREE
Vertex Pharma (NASDAQ: VRTX) February 14 weekly 480 straddle priced for movement of 5% into the expected release of quarter results after the bell on February 10.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alpine Income Property Trust, Inc. (PINE) Tops Q3 EPS by 1c
- Sezzle applies for national bank charter with OCC and FDIC
- Charles Schwab (SCHW) Declares $0.32 Quarterly Dividend; 1.4% Yield
Create E-mail Alert Related Categories
OptionsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
